Related Experiment Video
Updated: Jun 11, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
Epinephrine in resuscitation: curse or cure?
Robert R Attaran1, Gordon A Ewy
1University of Arizona College of Medicine, Tucson, AZ, USA.
Epinephrine is a critical cardiac arrest drug, but human trial evidence is limited. Intraosseous administration may speed delivery, but high-quality basic life support is crucial for survival.
Area of Science:
- Emergency Medicine
- Cardiology
- Pharmacology
Background:
- Epinephrine is a cornerstone of cardiac arrest management per established guidelines.
- Animal studies support its efficacy, yet robust human trial data remains scarce.
- Disparities in trial methodology contribute to the lack of conclusive human evidence.
Purpose of the Study:
- To review the role of epinephrine in cardiac arrest resuscitation.
- To explore reasons for the lack of demonstrated human efficacy.
- To discuss potential improvements in epinephrine administration and overall resuscitation quality.
Main Methods:
- Review of existing literature on epinephrine use in cardiac arrest.
- Analysis of pharmacologic and physiologic effects of epinephrine.
- Discussion of trial methodologies and administration delays.
Main Results:
- Epinephrine increases coronary perfusion pressure, vital for resuscitation success.
- Delayed administration in out-of-hospital cardiac arrest may explain limited trial efficacy.
- Intraosseous epinephrine offers a potential route for faster administration.
Conclusions:
- While epinephrine's role is established, human evidence is limited.
- Optimizing administration, such as via intraosseous route, could be beneficial.
- High-quality basic life support, including chest compressions and defibrillation, is paramount for survival.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation I: Adult
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

